Correlation Between Entegris and MusclePharm

Can any of the company-specific risk be diversified away by investing in both Entegris and MusclePharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entegris and MusclePharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entegris and MusclePharm, you can compare the effects of market volatilities on Entegris and MusclePharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entegris with a short position of MusclePharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entegris and MusclePharm.

Diversification Opportunities for Entegris and MusclePharm

0.0

Correlation Coefficient

Entegris  MusclePharm

Pay attention - limited upside

The 3 months correlation between Entegris and MusclePharm is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Entegris and MusclePharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MusclePharm and Entegris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entegris are associated (or correlated) with MusclePharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MusclePharm has no effect on the direction of Entegris i.e., Entegris and MusclePharm go up and down completely randomly.

Pair Corralation between Entegris and MusclePharm

If you would invest (100.00) in MusclePharm on December 22, 2024 and sell it today you would earn a total of  100.00  from holding MusclePharm or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Entegris  vs.  MusclePharm

Entegris

Risk-Adjusted Performance

Very Weak

Over the last 90 days Entegris has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Entegris is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

MusclePharm

Risk-Adjusted Performance

Very Weak

Over the last 90 days MusclePharm has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, MusclePharm is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Entegris and MusclePharm

The main advantage of trading using opposite Entegris and MusclePharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entegris position performs unexpectedly, MusclePharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MusclePharm will offset losses from the drop in MusclePharm's long position.

The idea behind Entegris and MusclePharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.